Related Experiment Video
Updated: Aug 22, 2025

Detection of Total Reactive Oxygen Species in Adherent Cells by 2',7'-Dichlorodihydrofluorescein Diacetate Staining
Published on: June 23, 2020
Transcription Factor FXR Activates DHRS9 to Inhibit the Cell Oxidative Phosphorylation and Suppress Colon Cancer
Jinlai Zhao1, Yigang Wang2, Yang Wang1
1Gastrointestinal surgery, Tangshan Central Hospital, Tangshan, Hebei 063000, China.
Background:
Colon cancer is a common gastrointestinal malignancy. It has been discovered that Farnesoid X receptor (FXR) plays an imperative regulatory role in multitype cancers in recent years. However, its regulatory mechanism in colon cancer has not been clearly explored. This study intended to explore the molecular regulatory mechanism of FXR and its downstream genes on the malignant progression of colon cancer.
Methods:
The mRNA and protein expression of FXR in colon cancer cells were measured by quantitative real-time polymerase chain reaction and Western blot. The effects of FXR on the biological function of colon cancer cells were measured by Cell Counting Kit-8, colony formation, and transwell assays. The downstream target gene of FXR was predicted by bioinformatics analysis and found to be associated with cellular oxidative phosphorylation. The binding relationship between FXR and its downstream gene dehydrogenase/reductase member 9 (DHRS9) was verified through luciferase reporter assay and chromatin immunoprecipitation assay. The changes of oxidative phosphorylation were detected by Western blot and oxygen consumption rate determination. The effect of FXR/DHRS9 axis on the malignant progression of colon cancer cells was further confirmed by rescue experiments.
Results:
FXR was underexpressed in colon cancer tissues and cells, and overexpressing FXR could repress the malignant behaviors of colon cancer cells. Besides, DHRS9 was a downstream gene of FXR, and FXR/DHRS9 inhibited the deterioration of colon cancer through inhibiting oxidative phosphorylation. Moreover, promoting FXR expression in colon cancer cells could partially reverse the biological function changes caused by silencing DHRS9 expression.
Conclusion:
FXR inhibited the oxidative phosphorylation and inhibited the malignant progression of colon cancer cells via targeting DHRS9.
Insights
Farnesoid X receptor (FXR) is underexpressed in colon cancer. Upregulating FXR and its target gene DHRS9 inhibits colon cancer progression by suppressing oxidative phosphorylation.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Colon cancer is a prevalent gastrointestinal malignancy.
- Farnesoid X receptor (FXR) is increasingly recognized for its regulatory role in various cancers.
- The specific mechanisms of FXR in colon cancer remain underexplored.
Purpose of the Study:
- To elucidate the molecular regulatory mechanism of FXR and its downstream targets in colon cancer progression.
- To investigate the role of the FXR/DHRS9 axis in colon cancer pathogenesis.
- To determine the impact of FXR on cellular oxidative phosphorylation in colon cancer.
Main Methods:
- Quantitative real-time PCR and Western blot to assess FXR expression.
- Cell Counting Kit-8, colony formation, and Transwell assays to evaluate cellular functions.
- Bioinformatics, luciferase reporter assays, and ChIP assays to identify and validate FXR's downstream target DHRS9.
- Oxygen consumption rate determination to measure oxidative phosphorylation.
Main Results:
- FXR expression was found to be downregulated in colon cancer tissues and cells.
- Overexpression of FXR suppressed malignant behaviors of colon cancer cells.
- DHRS9 was identified as a downstream target of FXR, and the FXR/DHRS9 axis inhibited colon cancer progression by suppressing oxidative phosphorylation.
- Restoring FXR expression partially reversed biological function changes induced by DHRS9 silencing.
Conclusions:
- FXR inhibits colon cancer cell progression by targeting DHRS9 and suppressing oxidative phosphorylation.
- The FXR/DHRS9 pathway represents a potential therapeutic target for colon cancer treatment.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Master Transcription Regulators
Transcriptional Regulation: Riboswitches
Co-activators and Co-repressors

